| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.69M | - | |
| Other | 52.8K | $8.53M | - | |
| Other | 46.8K | $7.56M | - | |
| Other | 39.6K | $6.41M | -36,937 | |
| Other | 36.8K | $5.96M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 2,996 | $154.01 | $461,422.95 | -7.0% | -18.8% | -15.8% | |
| Jul 16, 2024 | Cooke Julie59 | Chief Human Resources Officer | Sale+OE | 900 | $150.04 | $135,036.00 | -4.7% | -21.0% | -9.5% | |
| Jul 16, 2024 | Delaet Ingrid67 | Chief Regulatory Officer | Sale+OE | 2,857 | $150.03 | $428,627.00 | -11.7% | -21.0% | -9.5% | |
| Jul 16, 2024 | Lyons Gary A54 | Director | Sale+OE | 930 | $150.03 | $139,530.23 | -0.8% | -21.0% | -9.5% | |
| Jul 16, 2024 | Abernethy Matt57 | Chief Financial Officer | Sale+OE | 900 | $150.04 | $135,036.99 | -2.8% | -21.0% | -9.5% | |
| Jul 16, 2024 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 7,004 | $150.00 | $1,050,590.19 | -15.0% | -21.0% | -9.5% | |
| Jul 1, 2024 | Cooke Julie59 | Chief Human Resources Officer | Sale+OE | 10,000 | $140.19 | $1,401,864.00 | -35.5% | -17.8% | -8.6% | |
| Jul 1, 2024 | Delaet Ingrid67 | Chief Regulatory Officer | Sale+OE | 272 | $138.11 | $37,565.92 | -3.5% | -17.8% | -8.6% | |
| May 31, 2024 | Delaet Ingrid67 | Chief Regulatory Officer | Sale+OE | 273 | $136.55 | $37,278.15 | -3.5% | -5.2% | -9.1% | |
| May 29, 2024 | Sherwin Stephen A | Director | Sale+OE | 40,000 | $133.46 | $5,338,564.50 | -43.0% | +13.3% | -8.1% |